The investment seeks to provide current income; the fund’s secondary investment objective is to provide exposure to the price return of common shares of MARA Holdings, Inc... Show more
The Moving Average Convergence Divergence (MACD) for IMRA turned positive on August 18, 2025. Looking at past instances where IMRA's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on September 09, 2025. You may want to consider a long position or call options on IMRA as a result. In of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMRA advanced for three days, in of 131 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
IMRA broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IMRA entered a downward trend on August 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
a company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies
Category Trading